

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | actin-myosin filament sliding (GO:0033275) | 6.19400977 |
| 2 | muscle filament sliding (GO:0030049) | 6.19400977 |
| 3 | DNA deamination (GO:0045006) | 6.04270455 |
| 4 | NADH metabolic process (GO:0006734) | 5.98246501 |
| 5 | DNA strand elongation involved in DNA replication (GO:0006271) | 5.18699609 |
| 6 | ribosomal small subunit assembly (GO:0000028) | 5.17459369 |
| 7 | telomere maintenance via semi-conservative replication (GO:0032201) | 5.01748213 |
| 8 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 4.95411845 |
| 9 | DNA strand elongation (GO:0022616) | 4.92434036 |
| 10 | DNA replication initiation (GO:0006270) | 4.76405944 |
| 11 | actin-mediated cell contraction (GO:0070252) | 4.75654806 |
| 12 | maturation of SSU-rRNA (GO:0030490) | 4.64716755 |
| 13 | skeletal muscle contraction (GO:0003009) | 4.59739575 |
| 14 | regulation of skeletal muscle contraction (GO:0014819) | 4.58502461 |
| 15 | creatine metabolic process (GO:0006600) | 4.55913842 |
| 16 | oxidative phosphorylation (GO:0006119) | 4.45052009 |
| 17 | telomere maintenance via recombination (GO:0000722) | 4.40498485 |
| 18 | respiratory electron transport chain (GO:0022904) | 4.35842450 |
| 19 | tricarboxylic acid cycle (GO:0006099) | 4.33798520 |
| 20 | viral transcription (GO:0019083) | 4.29026834 |
| 21 | DNA replication checkpoint (GO:0000076) | 4.25959018 |
| 22 | electron transport chain (GO:0022900) | 4.24919574 |
| 23 | proteasome assembly (GO:0043248) | 4.24095796 |
| 24 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 4.23189375 |
| 25 | ribosomal large subunit biogenesis (GO:0042273) | 4.20810371 |
| 26 | translational termination (GO:0006415) | 4.20526090 |
| 27 | formation of translation preinitiation complex (GO:0001731) | 4.17241921 |
| 28 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 4.14285850 |
| 29 | nucleobase biosynthetic process (GO:0046112) | 4.04435638 |
| 30 | ribosomal small subunit biogenesis (GO:0042274) | 4.03078551 |
| 31 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 4.02748108 |
| 32 | translational elongation (GO:0006414) | 3.98858357 |
| 33 | mitotic recombination (GO:0006312) | 3.98772912 |
| 34 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.97745330 |
| 35 | mitotic metaphase plate congression (GO:0007080) | 3.97387446 |
| 36 | pseudouridine synthesis (GO:0001522) | 3.92591595 |
| 37 | CENP-A containing nucleosome assembly (GO:0034080) | 3.90568834 |
| 38 | rRNA modification (GO:0000154) | 3.90142971 |
| 39 | telomere maintenance via telomere lengthening (GO:0010833) | 3.88863055 |
| 40 | purine nucleobase biosynthetic process (GO:0009113) | 3.87440815 |
| 41 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.85407890 |
| 42 | ATP synthesis coupled proton transport (GO:0015986) | 3.85066103 |
| 43 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.85066103 |
| 44 | translational initiation (GO:0006413) | 3.84195036 |
| 45 | gluconeogenesis (GO:0006094) | 3.82145933 |
| 46 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 3.82038670 |
| 47 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.81113950 |
| 48 | regulation of relaxation of muscle (GO:1901077) | 3.77302541 |
| 49 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 3.76663169 |
| 50 | chromatin remodeling at centromere (GO:0031055) | 3.76595191 |
| 51 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.76122218 |
| 52 | cotranslational protein targeting to membrane (GO:0006613) | 3.67291587 |
| 53 | protein targeting to ER (GO:0045047) | 3.64848582 |
| 54 | oxaloacetate metabolic process (GO:0006107) | 3.61680430 |
| 55 | DNA unwinding involved in DNA replication (GO:0006268) | 3.61559048 |
| 56 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.61545254 |
| 57 | sarcomere organization (GO:0045214) | 3.60980467 |
| 58 | striated muscle contraction (GO:0006941) | 3.59783201 |
| 59 | folic acid metabolic process (GO:0046655) | 3.59084512 |
| 60 | iron-sulfur cluster assembly (GO:0016226) | 3.56264910 |
| 61 | metallo-sulfur cluster assembly (GO:0031163) | 3.56264910 |
| 62 | protein maturation by protein folding (GO:0022417) | 3.55769873 |
| 63 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.52016567 |
| 64 | rRNA processing (GO:0006364) | 3.51180438 |
| 65 | proline biosynthetic process (GO:0006561) | 3.51154110 |
| 66 | protein localization to endoplasmic reticulum (GO:0070972) | 3.49903022 |
| 67 | hexose biosynthetic process (GO:0019319) | 3.49357155 |
| 68 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.48153184 |
| 69 | termination of RNA polymerase III transcription (GO:0006386) | 3.48153184 |
| 70 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.47893369 |
| 71 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.47830056 |
| 72 | monosaccharide biosynthetic process (GO:0046364) | 3.42643864 |
| 73 | DNA replication-independent nucleosome organization (GO:0034724) | 3.42132254 |
| 74 | DNA replication-independent nucleosome assembly (GO:0006336) | 3.42132254 |
| 75 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.41388134 |
| 76 | metaphase plate congression (GO:0051310) | 3.39229521 |
| 77 | protein deneddylation (GO:0000338) | 3.38914348 |
| 78 | rRNA metabolic process (GO:0016072) | 3.38147614 |
| 79 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.36841440 |
| 80 | ubiquinone biosynthetic process (GO:0006744) | 3.35817466 |
| 81 | spliceosomal snRNP assembly (GO:0000387) | 3.35681320 |
| 82 | heart process (GO:0003015) | 3.35196911 |
| 83 | heart contraction (GO:0060047) | 3.35196911 |
| 84 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.34974592 |
| 85 | translation (GO:0006412) | 3.30145348 |
| 86 | ribosome biogenesis (GO:0042254) | 3.30060656 |
| 87 | cellular protein complex disassembly (GO:0043624) | 3.29769645 |
| 88 | transcription-coupled nucleotide-excision repair (GO:0006283) | 3.28894564 |
| 89 | ribosome assembly (GO:0042255) | 3.28821513 |
| 90 | glucan biosynthetic process (GO:0009250) | 3.28454835 |
| 91 | glycogen biosynthetic process (GO:0005978) | 3.28454835 |
| 92 | amino acid salvage (GO:0043102) | 3.27157763 |
| 93 | L-methionine salvage (GO:0071267) | 3.27157763 |
| 94 | L-methionine biosynthetic process (GO:0071265) | 3.27157763 |
| 95 | viral life cycle (GO:0019058) | 3.26643591 |
| 96 | galactose catabolic process (GO:0019388) | 3.26307663 |
| 97 | GDP-mannose metabolic process (GO:0019673) | 3.24496359 |
| 98 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.23758569 |
| 99 | negative regulation of ligase activity (GO:0051352) | 3.23758569 |
| 100 | kinetochore assembly (GO:0051382) | 3.21502606 |
| 101 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.19240547 |
| 102 | protein localization to kinetochore (GO:0034501) | 3.16886416 |
| 103 | G1/S transition of mitotic cell cycle (GO:0000082) | 3.14322255 |
| 104 | cell cycle G1/S phase transition (GO:0044843) | 3.14322255 |
| 105 | rRNA methylation (GO:0031167) | 3.14075670 |
| 106 | kinetochore organization (GO:0051383) | 3.13159459 |
| 107 | nucleoside diphosphate biosynthetic process (GO:0009133) | 3.12730892 |
| 108 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.12437279 |
| 109 | deoxyribonucleotide biosynthetic process (GO:0009263) | 3.11845786 |
| 110 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 3.11584178 |
| 111 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.11323719 |
| 112 | cardiac muscle contraction (GO:0060048) | 3.10143897 |
| 113 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.07771890 |
| 114 | actin filament-based movement (GO:0030048) | 3.07722546 |
| 115 | mitotic nuclear envelope disassembly (GO:0007077) | 3.06538986 |
| 116 | protein localization to chromosome, centromeric region (GO:0071459) | 3.05476271 |
| 117 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 3.04860982 |
| 118 | deoxyribose phosphate biosynthetic process (GO:0046385) | 3.04860982 |
| 119 | histone exchange (GO:0043486) | 3.04573238 |
| 120 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.03910758 |
| 121 | response to muscle activity (GO:0014850) | 3.02444769 |
| 122 | spliceosomal complex assembly (GO:0000245) | 3.02257780 |
| 123 | cellular component biogenesis (GO:0044085) | 3.01954857 |
| 124 | skeletal muscle fiber development (GO:0048741) | 3.01740006 |
| 125 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.01418469 |
| 126 | regulation of double-strand break repair via homologous recombination (GO:0010569) | 3.01177324 |
| 127 | fructose metabolic process (GO:0006000) | 3.00588958 |
| 128 | quinone biosynthetic process (GO:1901663) | 3.00521804 |
| 129 | glycogen catabolic process (GO:0005980) | 2.99417017 |
| 130 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.99196539 |
| 131 | IMP biosynthetic process (GO:0006188) | 2.98894947 |
| 132 | 2-oxoglutarate metabolic process (GO:0006103) | 2.98091068 |
| 133 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.97158449 |
| 134 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.97050061 |
| 135 | nucleotide salvage (GO:0043173) | 2.96621070 |
| 136 | heme biosynthetic process (GO:0006783) | 2.96586741 |
| 137 | establishment of chromosome localization (GO:0051303) | 2.96542782 |
| 138 | attachment of spindle microtubules to kinetochore (GO:0008608) | 2.94061684 |
| 139 | IMP metabolic process (GO:0046040) | 2.92707723 |
| 140 | protein complex disassembly (GO:0043241) | 2.92002165 |
| 141 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.91737834 |
| 142 | heme metabolic process (GO:0042168) | 2.91523753 |
| 143 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.90994177 |
| 144 | L-phenylalanine metabolic process (GO:0006558) | 2.90994177 |
| 145 | protein targeting to mitochondrion (GO:0006626) | 2.90870230 |
| 146 | regulation of mitochondrial translation (GO:0070129) | 2.90588793 |
| 147 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.90455370 |
| 148 | mitotic chromosome condensation (GO:0007076) | 2.89846807 |
| 149 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.89842488 |
| 150 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.89842488 |
| 151 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.89372569 |
| 152 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.89372569 |
| 153 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.89372569 |
| 154 | 7-methylguanosine mRNA capping (GO:0006370) | 2.88872087 |
| 155 | pyrimidine nucleoside triphosphate metabolic process (GO:0009147) | 2.87959473 |
| 156 | positive regulation of ligase activity (GO:0051351) | 2.87697648 |
| 157 | mitochondrial transport (GO:0006839) | 2.82888143 |
| 158 | ubiquinone metabolic process (GO:0006743) | 2.81943584 |
| 159 | lipopolysaccharide biosynthetic process (GO:0009103) | 2.81417064 |
| 160 | glycosphingolipid catabolic process (GO:0046479) | 2.80491792 |
| 161 | mitochondrial calcium ion homeostasis (GO:0051560) | 2.80464044 |
| 162 | tricarboxylic acid metabolic process (GO:0072350) | 2.79174980 |
| 163 | COPI coating of Golgi vesicle (GO:0048205) | 2.78858947 |
| 164 | Golgi transport vesicle coating (GO:0048200) | 2.78858947 |
| 165 | aerobic respiration (GO:0009060) | 2.78186326 |
| 166 | purine nucleotide salvage (GO:0032261) | 2.77342052 |
| 167 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.77078358 |
| 168 | glucan catabolic process (GO:0009251) | 2.76193292 |
| 169 | negative regulation of cell size (GO:0045792) | 2.75995526 |
| 170 | protein retention in ER lumen (GO:0006621) | 2.75544933 |
| 171 | ATP biosynthetic process (GO:0006754) | 2.75371564 |
| 172 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.74616839 |
| 173 | myotube cell development (GO:0014904) | 2.73473624 |
| 174 | establishment of protein localization to mitochondrion (GO:0072655) | 2.72355811 |
| 175 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.70781208 |
| 176 | viral protein processing (GO:0019082) | 2.66097793 |
| 177 | mitochondrial fusion (GO:0008053) | 2.65127912 |
| 178 | myofibril assembly (GO:0030239) | 2.64702284 |
| 179 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.64485688 |
| 180 | fatty acid beta-oxidation (GO:0006635) | 2.63299734 |
| 181 | base-excision repair, AP site formation (GO:0006285) | 2.63000516 |
| 182 | regulation of cellular respiration (GO:0043457) | 2.62438880 |
| 183 | protein complex biogenesis (GO:0070271) | 2.61479999 |
| 184 | hydrogen ion transmembrane transport (GO:1902600) | 2.60524467 |
| 185 | glycolipid catabolic process (GO:0019377) | 2.58882004 |
| 186 | succinate metabolic process (GO:0006105) | 2.57799697 |
| 187 | cellular carbohydrate biosynthetic process (GO:0034637) | 2.57246028 |
| 188 | muscle contraction (GO:0006936) | 2.57204376 |
| 189 | protein localization to mitochondrion (GO:0070585) | 2.56123045 |
| 190 | UV protection (GO:0009650) | 2.55316969 |
| 191 | negative regulation of necroptotic process (GO:0060546) | 2.55200713 |
| 192 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.54208091 |
| 193 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.54208091 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 7.21263318 |
| 2 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 4.23342263 |
| 3 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 4.21303662 |
| 4 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.78407687 |
| 5 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.45065857 |
| 6 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.39034111 |
| 7 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.20691780 |
| 8 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.08218848 |
| 9 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.08161781 |
| 10 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 3.06140127 |
| 11 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.95990338 |
| 12 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.95750476 |
| 13 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.91656739 |
| 14 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.81024309 |
| 15 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.75334718 |
| 16 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.73171564 |
| 17 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.62084442 |
| 18 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.45103728 |
| 19 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.44017569 |
| 20 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.43814648 |
| 21 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.32088015 |
| 22 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.22220212 |
| 23 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.17552304 |
| 24 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.16437307 |
| 25 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.16008058 |
| 26 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.15821001 |
| 27 | GABP_19822575_ChIP-Seq_HepG2_Human | 2.12822044 |
| 28 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.12150854 |
| 29 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.11869303 |
| 30 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.08342357 |
| 31 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.06049506 |
| 32 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.05948156 |
| 33 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 2.04338056 |
| 34 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.03987319 |
| 35 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.03705655 |
| 36 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.01624573 |
| 37 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.01621105 |
| 38 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.01427351 |
| 39 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.91233979 |
| 40 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.90591843 |
| 41 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.86903384 |
| 42 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.78530268 |
| 43 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.78143917 |
| 44 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.77001401 |
| 45 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.76370140 |
| 46 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.75569911 |
| 47 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.75078687 |
| 48 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.75038309 |
| 49 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.74517990 |
| 50 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.73224834 |
| 51 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.71921708 |
| 52 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.67593932 |
| 53 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.67036162 |
| 54 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.65833960 |
| 55 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.63671379 |
| 56 | P68_20966046_ChIP-Seq_HELA_Human | 1.60497540 |
| 57 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.59086967 |
| 58 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.58878985 |
| 59 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.58658667 |
| 60 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.58639594 |
| 61 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.57247321 |
| 62 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.55814041 |
| 63 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.54365930 |
| 64 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.52282710 |
| 65 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.48551866 |
| 66 | MYC_22102868_ChIP-Seq_BL_Human | 1.47849229 |
| 67 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.47602988 |
| 68 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.47506779 |
| 69 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.46044676 |
| 70 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.43214708 |
| 71 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.42215699 |
| 72 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.42052398 |
| 73 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.40711251 |
| 74 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.39682722 |
| 75 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.38026621 |
| 76 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.37163429 |
| 77 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.34987775 |
| 78 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.31566697 |
| 79 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.29197599 |
| 80 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.28990392 |
| 81 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.28570961 |
| 82 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.27833309 |
| 83 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.27632247 |
| 84 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.27616177 |
| 85 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.26704075 |
| 86 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.26067512 |
| 87 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.26002764 |
| 88 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.25391831 |
| 89 | SA1_27219007_Chip-Seq_Bcells_Human | 1.25210667 |
| 90 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.23086838 |
| 91 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.23008200 |
| 92 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.19857883 |
| 93 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.18290068 |
| 94 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.18020543 |
| 95 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.16148872 |
| 96 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.14544987 |
| 97 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.12717272 |
| 98 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.12514993 |
| 99 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.08303249 |
| 100 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.08182733 |
| 101 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.07840557 |
| 102 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.07089971 |
| 103 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 1.05948082 |
| 104 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.05934666 |
| 105 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.05515919 |
| 106 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.05436239 |
| 107 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.05271702 |
| 108 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.04948125 |
| 109 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.04919351 |
| 110 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.04825146 |
| 111 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.03978530 |
| 112 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.03751006 |
| 113 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.03127736 |
| 114 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.00759746 |
| 115 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.00639229 |
| 116 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.00588876 |
| 117 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.00010743 |
| 118 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.99991326 |
| 119 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.99331955 |
| 120 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.98698727 |
| 121 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.97800566 |
| 122 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.97788053 |
| 123 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.97685242 |
| 124 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.97034869 |
| 125 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.96106516 |
| 126 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.95583555 |
| 127 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.95556290 |
| 128 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.92877692 |
| 129 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.92567546 |
| 130 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.90286242 |
| 131 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.90075356 |
| 132 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.89693720 |
| 133 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.89466313 |
| 134 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89262772 |
| 135 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.85492238 |
| 136 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.84299627 |
| 137 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.83703516 |
| 138 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.82153951 |
| 139 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.81918505 |
| 140 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.81844100 |
| 141 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.80339316 |
| 142 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.78981798 |
| 143 | TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 0.78972549 |
| 144 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.78330800 |
| 145 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.78081000 |
| 146 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.78059844 |
| 147 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.76661000 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003693_abnormal_embryo_hatching | 6.12415179 |
| 2 | MP0000751_myopathy | 4.78995655 |
| 3 | MP0010094_abnormal_chromosome_stability | 4.70412740 |
| 4 | MP0003111_abnormal_nucleus_morphology | 4.69322312 |
| 5 | MP0004957_abnormal_blastocyst_morpholog | 4.66380074 |
| 6 | MP0000749_muscle_degeneration | 4.18892862 |
| 7 | MP0003077_abnormal_cell_cycle | 3.93635467 |
| 8 | MP0004145_abnormal_muscle_electrophysio | 3.83176091 |
| 9 | MP0003806_abnormal_nucleotide_metabolis | 3.11527103 |
| 10 | MP0002396_abnormal_hematopoietic_system | 3.05943596 |
| 11 | MP0005058_abnormal_lysosome_morphology | 3.05655448 |
| 12 | MP0008058_abnormal_DNA_repair | 2.94825930 |
| 13 | MP0004036_abnormal_muscle_relaxation | 2.88149506 |
| 14 | MP0008057_abnormal_DNA_replication | 2.85807037 |
| 15 | MP0000747_muscle_weakness | 2.84904959 |
| 16 | MP0000759_abnormal_skeletal_muscle | 2.62522649 |
| 17 | MP0004233_abnormal_muscle_weight | 2.61432378 |
| 18 | MP0003718_maternal_effect | 2.55880407 |
| 19 | MP0005670_abnormal_white_adipose | 2.51946895 |
| 20 | MP0004087_abnormal_muscle_fiber | 2.39923923 |
| 21 | MP0008007_abnormal_cellular_replicative | 2.37482414 |
| 22 | MP0008932_abnormal_embryonic_tissue | 2.36620574 |
| 23 | MP0002837_dystrophic_cardiac_calcinosis | 2.33198294 |
| 24 | MP0002106_abnormal_muscle_physiology | 2.31855711 |
| 25 | MP0004130_abnormal_muscle_cell | 2.23677264 |
| 26 | MP0000490_abnormal_crypts_of | 2.10561145 |
| 27 | MP0002269_muscular_atrophy | 2.10023404 |
| 28 | MP0001730_embryonic_growth_arrest | 2.06732223 |
| 29 | MP0002332_abnormal_exercise_endurance | 2.06437174 |
| 30 | MP0003646_muscle_fatigue | 2.05528167 |
| 31 | MP0003763_abnormal_thymus_physiology | 2.05172969 |
| 32 | MP0002139_abnormal_hepatobiliary_system | 2.04395918 |
| 33 | MP0002132_abnormal_respiratory_system | 2.02125407 |
| 34 | MP0006036_abnormal_mitochondrial_physio | 1.98486852 |
| 35 | MP0003786_premature_aging | 1.93649990 |
| 36 | MP0005369_muscle_phenotype | 1.86456922 |
| 37 | MP0003656_abnormal_erythrocyte_physiolo | 1.85229663 |
| 38 | MP0003191_abnormal_cellular_cholesterol | 1.83342779 |
| 39 | MP0000350_abnormal_cell_proliferation | 1.76423140 |
| 40 | MP0003186_abnormal_redox_activity | 1.75266986 |
| 41 | MP0002972_abnormal_cardiac_muscle | 1.74507183 |
| 42 | MP0005620_abnormal_muscle_contractility | 1.73723143 |
| 43 | MP0009333_abnormal_splenocyte_physiolog | 1.73693202 |
| 44 | MP0004084_abnormal_cardiac_muscle | 1.72315441 |
| 45 | MP0005083_abnormal_biliary_tract | 1.69094878 |
| 46 | MP0001545_abnormal_hematopoietic_system | 1.68116833 |
| 47 | MP0005397_hematopoietic_system_phenotyp | 1.68116833 |
| 48 | MP0005360_urolithiasis | 1.63655011 |
| 49 | MP0002019_abnormal_tumor_incidence | 1.57297646 |
| 50 | MP0005365_abnormal_bile_salt | 1.56944319 |
| 51 | MP0004147_increased_porphyrin_level | 1.52670217 |
| 52 | MP0000465_gastrointestinal_hemorrhage | 1.51100862 |
| 53 | MP0000343_altered_response_to | 1.45562814 |
| 54 | MP0003123_paternal_imprinting | 1.43021869 |
| 55 | MP0000313_abnormal_cell_death | 1.42521719 |
| 56 | MP0001697_abnormal_embryo_size | 1.38990084 |
| 57 | MP0010352_gastrointestinal_tract_polyps | 1.38306348 |
| 58 | MP0002080_prenatal_lethality | 1.37925898 |
| 59 | MP0004510_myositis | 1.36880419 |
| 60 | MP0004215_abnormal_myocardial_fiber | 1.35869891 |
| 61 | MP0006292_abnormal_olfactory_placode | 1.35044478 |
| 62 | MP0002971_abnormal_brown_adipose | 1.33882989 |
| 63 | MP0002398_abnormal_bone_marrow | 1.33381571 |
| 64 | MP0005666_abnormal_adipose_tissue | 1.33232107 |
| 65 | MP0000733_abnormal_muscle_development | 1.32921908 |
| 66 | MP0006035_abnormal_mitochondrial_morpho | 1.31534132 |
| 67 | MP0008877_abnormal_DNA_methylation | 1.30655864 |
| 68 | MP0005165_increased_susceptibility_to | 1.30604282 |
| 69 | MP0003879_abnormal_hair_cell | 1.28647479 |
| 70 | MP0002163_abnormal_gland_morphology | 1.27407549 |
| 71 | MP0002722_abnormal_immune_system | 1.25937542 |
| 72 | MP0003137_abnormal_impulse_conducting | 1.25881818 |
| 73 | MP0000689_abnormal_spleen_morphology | 1.25538231 |
| 74 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.22748080 |
| 75 | MP0005332_abnormal_amino_acid | 1.22314570 |
| 76 | MP0003950_abnormal_plasma_membrane | 1.21859425 |
| 77 | MP0004808_abnormal_hematopoietic_stem | 1.19526552 |
| 78 | MP0000703_abnormal_thymus_morphology | 1.18674552 |
| 79 | MP0009379_abnormal_foot_pigmentation | 1.18564761 |
| 80 | MP0001672_abnormal_embryogenesis/_devel | 1.16988193 |
| 81 | MP0005380_embryogenesis_phenotype | 1.16988193 |
| 82 | MP0005075_abnormal_melanosome_morpholog | 1.16781160 |
| 83 | MP0001529_abnormal_vocalization | 1.15901995 |
| 84 | MP0009840_abnormal_foam_cell | 1.15710030 |
| 85 | MP0005385_cardiovascular_system_phenoty | 1.13277718 |
| 86 | MP0001544_abnormal_cardiovascular_syste | 1.13277718 |
| 87 | MP0000358_abnormal_cell_content/ | 1.12511153 |
| 88 | MP0004185_abnormal_adipocyte_glucose | 1.12126863 |
| 89 | MP0002210_abnormal_sex_determination | 1.11574214 |
| 90 | MP0001661_extended_life_span | 1.10566227 |
| 91 | MP0001929_abnormal_gametogenesis | 1.10119343 |
| 92 | MP0005375_adipose_tissue_phenotype | 1.09342535 |
| 93 | MP0003075_altered_response_to | 1.09041297 |
| 94 | MP0002429_abnormal_blood_cell | 1.07762786 |
| 95 | MP0006138_congestive_heart_failure | 1.07609883 |
| 96 | MP0001764_abnormal_homeostasis | 1.04474953 |
| 97 | MP0000003_abnormal_adipose_tissue | 1.03821298 |
| 98 | MP0001145_abnormal_male_reproductive | 1.02579134 |
| 99 | MP0003984_embryonic_growth_retardation | 1.02497057 |
| 100 | MP0001853_heart_inflammation | 1.00198771 |
| 101 | MP0002088_abnormal_embryonic_growth/wei | 0.97243291 |
| 102 | MP0000653_abnormal_sex_gland | 0.95844736 |
| 103 | MP0010630_abnormal_cardiac_muscle | 0.95424598 |
| 104 | MP0002127_abnormal_cardiovascular_syste | 0.93547771 |
| 105 | MP0000013_abnormal_adipose_tissue | 0.92764690 |
| 106 | MP0003221_abnormal_cardiomyocyte_apopto | 0.92620688 |
| 107 | MP0000716_abnormal_immune_system | 0.92461447 |
| 108 | MP0001873_stomach_inflammation | 0.91790570 |
| 109 | MP0002085_abnormal_embryonic_tissue | 0.91697559 |
| 110 | MP0010030_abnormal_orbit_morphology | 0.91544508 |
| 111 | MP0003011_delayed_dark_adaptation | 0.91541689 |
| 112 | MP0006054_spinal_hemorrhage | 0.89272882 |
| 113 | MP0002086_abnormal_extraembryonic_tissu | 0.86490688 |
| 114 | MP0005220_abnormal_exocrine_pancreas | 0.86110414 |
| 115 | MP0000685_abnormal_immune_system | 0.84501825 |
| 116 | MP0005451_abnormal_body_composition | 0.82418567 |
| 117 | MP0003705_abnormal_hypodermis_morpholog | 0.81073066 |
| 118 | MP0005266_abnormal_metabolism | 0.79969718 |
| 119 | MP0000372_irregular_coat_pigmentation | 0.79957912 |
| 120 | MP0005671_abnormal_response_to | 0.79423518 |
| 121 | MP0002118_abnormal_lipid_homeostasis | 0.79227414 |
| 122 | MP0001119_abnormal_female_reproductive | 0.78475482 |
| 123 | MP0005636_abnormal_mineral_homeostasis | 0.77821870 |
| 124 | MP0005408_hypopigmentation | 0.77412583 |
| 125 | MP0001919_abnormal_reproductive_system | 0.76016618 |
| 126 | MP0002108_abnormal_muscle_morphology | 0.75517383 |
| 127 | MP0002405_respiratory_system_inflammati | 0.74733428 |
| 128 | MP0003567_abnormal_fetal_cardiomyocyte | 0.74524791 |
| 129 | MP0001727_abnormal_embryo_implantation | 0.73068499 |
| 130 | MP0000858_altered_metastatic_potential | 0.72868658 |
| 131 | MP0003959_abnormal_lean_body | 0.72310972 |
| 132 | MP0008789_abnormal_olfactory_epithelium | 0.72291612 |
| 133 | MP0008775_abnormal_heart_ventricle | 0.72191515 |
| 134 | MP0009697_abnormal_copulation | 0.72089554 |
| 135 | MP0009643_abnormal_urine_homeostasis | 0.70388239 |
| 136 | MP0002420_abnormal_adaptive_immunity | 0.69669462 |
| 137 | MP0005389_reproductive_system_phenotype | 0.69090986 |
| 138 | MP0003315_abnormal_perineum_morphology | 0.68885537 |
| 139 | MP0004858_abnormal_nervous_system | 0.68795411 |
| 140 | MP0005166_decreased_susceptibility_to | 0.68595309 |
| 141 | MP0002084_abnormal_developmental_patter | 0.67700036 |
| 142 | MP0002078_abnormal_glucose_homeostasis | 0.67564921 |
| 143 | MP0003699_abnormal_female_reproductive | 0.67293899 |
| 144 | MP0003866_abnormal_defecation | 0.66842693 |
| 145 | MP0002095_abnormal_skin_pigmentation | 0.66444674 |
| 146 | MP0001819_abnormal_immune_cell | 0.65685409 |
| 147 | MP0000750_abnormal_muscle_regeneration | 0.65020592 |
| 148 | MP0005395_other_phenotype | 0.64937609 |
| 149 | MP0001800_abnormal_humoral_immune | 0.64873541 |
| 150 | MP0001542_abnormal_bone_strength | 0.64723039 |
| 151 | MP0005384_cellular_phenotype | 0.64495180 |
| 152 | MP0003329_amyloid_beta_deposits | 0.64367650 |
| 153 | MP0010307_abnormal_tumor_latency | 0.64363344 |
| 154 | MP0008874_decreased_physiological_sensi | 0.63094855 |
| 155 | MP0000678_abnormal_parathyroid_gland | 0.62918246 |
| 156 | MP0005464_abnormal_platelet_physiology | 0.62531293 |
| 157 | MP0005535_abnormal_body_temperature | 0.60797202 |
| 158 | MP0009672_abnormal_birth_weight | 0.60548029 |
| 159 | MP0002653_abnormal_ependyma_morphology | 0.60390839 |
| 160 | MP0002970_abnormal_white_adipose | 0.59925108 |
| 161 | MP0000609_abnormal_liver_physiology | 0.59667210 |
| 162 | MP0010329_abnormal_lipoprotein_level | 0.59629108 |
| 163 | MP0002102_abnormal_ear_morphology | 0.59381507 |
| 164 | MP0002822_catalepsy | 0.58909593 |
| 165 | MP0005621_abnormal_cell_physiology | 0.58818739 |
| 166 | MP0005330_cardiomyopathy | 0.58689754 |
| 167 | MP0005334_abnormal_fat_pad | 0.57224076 |
| 168 | MP0000613_abnormal_salivary_gland | 0.56441086 |
| 169 | MP0005501_abnormal_skin_physiology | 0.56263435 |
| 170 | MP0005452_abnormal_adipose_tissue | 0.55787629 |
| 171 | MP0004484_altered_response_of | 0.55548424 |
| 172 | MP0005319_abnormal_enzyme/_coenzyme | 0.55520202 |
| 173 | MP0000477_abnormal_intestine_morphology | 0.55439562 |
| 174 | MP0000604_amyloidosis | 0.54363749 |
| 175 | MP0009384_cardiac_valve_regurgitation | 0.50919439 |
| 176 | MP0008260_abnormal_autophagy | 0.50748663 |
| 177 | MP0008438_abnormal_cutaneous_collagen | 0.50446184 |
| 178 | MP0002638_abnormal_pupillary_reflex | 0.50129241 |
| 179 | MP0001243_abnormal_dermal_layer | 0.50071408 |
| 180 | MP0005376_homeostasis/metabolism_phenot | 0.49332955 |
| 181 | MP0001905_abnormal_dopamine_level | 0.44689486 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nemaline bodies (HP:0003798) | 6.99095372 |
| 2 | Muscle fiber inclusion bodies (HP:0100299) | 6.89337809 |
| 3 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 6.75490479 |
| 4 | Abnormal number of erythroid precursors (HP:0012131) | 5.97479039 |
| 5 | Abnormality of cells of the erythroid lineage (HP:0012130) | 5.83526259 |
| 6 | Exercise-induced myalgia (HP:0003738) | 5.39119475 |
| 7 | Type 1 muscle fiber predominance (HP:0003803) | 5.09294728 |
| 8 | Birth length less than 3rd percentile (HP:0003561) | 5.09227954 |
| 9 | Rhabdomyolysis (HP:0003201) | 4.71191566 |
| 10 | Myopathic facies (HP:0002058) | 4.68209766 |
| 11 | Myoglobinuria (HP:0002913) | 4.35042776 |
| 12 | Oral leukoplakia (HP:0002745) | 4.33265307 |
| 13 | Exercise-induced muscle cramps (HP:0003710) | 4.31786967 |
| 14 | Aplastic anemia (HP:0001915) | 4.16138081 |
| 15 | Distal lower limb muscle weakness (HP:0009053) | 4.07809968 |
| 16 | Reticulocytopenia (HP:0001896) | 4.07424270 |
| 17 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 4.03709735 |
| 18 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 3.96078102 |
| 19 | Abnormality of alanine metabolism (HP:0010916) | 3.96078102 |
| 20 | Hyperalaninemia (HP:0003348) | 3.96078102 |
| 21 | Microretrognathia (HP:0000308) | 3.95996163 |
| 22 | Breast hypoplasia (HP:0003187) | 3.88799251 |
| 23 | EMG: myopathic abnormalities (HP:0003458) | 3.85944495 |
| 24 | Cerebral hypomyelination (HP:0006808) | 3.71454773 |
| 25 | Ragged-red muscle fibers (HP:0003200) | 3.69242525 |
| 26 | Macrocytic anemia (HP:0001972) | 3.65867572 |
| 27 | Neck muscle weakness (HP:0000467) | 3.51974937 |
| 28 | Rough bone trabeculation (HP:0100670) | 3.43338645 |
| 29 | Carpal bone hypoplasia (HP:0001498) | 3.32443496 |
| 30 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.32208702 |
| 31 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.32208702 |
| 32 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.24428052 |
| 33 | Pallor (HP:0000980) | 3.23983018 |
| 34 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.19523135 |
| 35 | Hepatocellular necrosis (HP:0001404) | 3.16546174 |
| 36 | Increased serum lactate (HP:0002151) | 3.15861011 |
| 37 | Muscle stiffness (HP:0003552) | 3.14291575 |
| 38 | Hepatic necrosis (HP:0002605) | 3.12585699 |
| 39 | Muscle fiber splitting (HP:0003555) | 3.11563648 |
| 40 | Hyporeflexia of lower limbs (HP:0002600) | 3.11346685 |
| 41 | Distal arthrogryposis (HP:0005684) | 3.11033876 |
| 42 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.05658272 |
| 43 | Bulbar palsy (HP:0001283) | 3.01959499 |
| 44 | Asymmetric septal hypertrophy (HP:0001670) | 2.92989549 |
| 45 | Increased CSF lactate (HP:0002490) | 2.86325723 |
| 46 | Increased connective tissue (HP:0009025) | 2.84042797 |
| 47 | 3-Methylglutaconic aciduria (HP:0003535) | 2.82481070 |
| 48 | Abnormality of the calf musculature (HP:0001430) | 2.81222219 |
| 49 | Mitochondrial inheritance (HP:0001427) | 2.80731782 |
| 50 | Increased hepatocellular lipid droplets (HP:0006565) | 2.79273295 |
| 51 | Lipid accumulation in hepatocytes (HP:0006561) | 2.78988183 |
| 52 | Sudden death (HP:0001699) | 2.77931317 |
| 53 | Round ear (HP:0100830) | 2.77645508 |
| 54 | Ulnar deviation of the wrist (HP:0003049) | 2.74843592 |
| 55 | Secondary amenorrhea (HP:0000869) | 2.74493845 |
| 56 | Colon cancer (HP:0003003) | 2.72965246 |
| 57 | Multiple enchondromatosis (HP:0005701) | 2.72619377 |
| 58 | Premature ovarian failure (HP:0008209) | 2.66899583 |
| 59 | Premature graying of hair (HP:0002216) | 2.64623256 |
| 60 | Calf muscle hypertrophy (HP:0008981) | 2.64449411 |
| 61 | Abnormality of glycolipid metabolism (HP:0010969) | 2.63589735 |
| 62 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.63589735 |
| 63 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.63589735 |
| 64 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.63574360 |
| 65 | Acute necrotizing encephalopathy (HP:0006965) | 2.63447084 |
| 66 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.57954916 |
| 67 | Pancytopenia (HP:0001876) | 2.57891275 |
| 68 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 2.57671177 |
| 69 | Patellar aplasia (HP:0006443) | 2.56799174 |
| 70 | Increased variability in muscle fiber diameter (HP:0003557) | 2.56190742 |
| 71 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.51058526 |
| 72 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.50823867 |
| 73 | Progressive muscle weakness (HP:0003323) | 2.48935016 |
| 74 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.48453221 |
| 75 | Lactic acidosis (HP:0003128) | 2.46052971 |
| 76 | Abnormality of the anterior horn cell (HP:0006802) | 2.46038983 |
| 77 | Degeneration of anterior horn cells (HP:0002398) | 2.46038983 |
| 78 | Acute encephalopathy (HP:0006846) | 2.45407497 |
| 79 | Respiratory difficulties (HP:0002880) | 2.44875378 |
| 80 | Rimmed vacuoles (HP:0003805) | 2.43620345 |
| 81 | Distal lower limb amyotrophy (HP:0008944) | 2.42296197 |
| 82 | Generalized aminoaciduria (HP:0002909) | 2.40631443 |
| 83 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 2.40050713 |
| 84 | Abnormal trabecular bone morphology (HP:0100671) | 2.38556532 |
| 85 | Increased intramyocellular lipid droplets (HP:0012240) | 2.37903244 |
| 86 | Exertional dyspnea (HP:0002875) | 2.34134606 |
| 87 | Increased muscle lipid content (HP:0009058) | 2.33133193 |
| 88 | Abnormal spermatogenesis (HP:0008669) | 2.32953161 |
| 89 | Unsteady gait (HP:0002317) | 2.32626112 |
| 90 | Bundle branch block (HP:0011710) | 2.32332264 |
| 91 | Myotonia (HP:0002486) | 2.30985644 |
| 92 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.29653831 |
| 93 | Abnormality of chromosome stability (HP:0003220) | 2.28871164 |
| 94 | CNS hypomyelination (HP:0003429) | 2.25334968 |
| 95 | Cerebral palsy (HP:0100021) | 2.24847739 |
| 96 | Emotional lability (HP:0000712) | 2.23529039 |
| 97 | Sparse eyelashes (HP:0000653) | 2.22704987 |
| 98 | Renal Fanconi syndrome (HP:0001994) | 2.21986177 |
| 99 | Bone marrow hypocellularity (HP:0005528) | 2.21645808 |
| 100 | Abnormality of the preputium (HP:0100587) | 2.21511485 |
| 101 | Lipoatrophy (HP:0100578) | 2.21430295 |
| 102 | Dilated cardiomyopathy (HP:0001644) | 2.19928174 |
| 103 | CNS demyelination (HP:0007305) | 2.19780768 |
| 104 | Cellular immunodeficiency (HP:0005374) | 2.19734794 |
| 105 | Increased serum pyruvate (HP:0003542) | 2.19635046 |
| 106 | Abnormality of glycolysis (HP:0004366) | 2.19635046 |
| 107 | Megaloblastic anemia (HP:0001889) | 2.19625588 |
| 108 | Cerebral edema (HP:0002181) | 2.17286750 |
| 109 | Microvesicular hepatic steatosis (HP:0001414) | 2.16691067 |
| 110 | Vertebral compression fractures (HP:0002953) | 2.16566161 |
| 111 | Chromsome breakage (HP:0040012) | 2.15758861 |
| 112 | Death in infancy (HP:0001522) | 2.15448020 |
| 113 | Trismus (HP:0000211) | 2.15197200 |
| 114 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.13044170 |
| 115 | Progressive macrocephaly (HP:0004481) | 2.12432837 |
| 116 | Irregular epiphyses (HP:0010582) | 2.11580638 |
| 117 | Generalized muscle weakness (HP:0003324) | 2.10085805 |
| 118 | Muscle fiber atrophy (HP:0100295) | 2.09755952 |
| 119 | Areflexia of lower limbs (HP:0002522) | 2.07767972 |
| 120 | IgM deficiency (HP:0002850) | 2.06476538 |
| 121 | Selective tooth agenesis (HP:0001592) | 2.04899173 |
| 122 | Thrombocytosis (HP:0001894) | 2.02991862 |
| 123 | Cholelithiasis (HP:0001081) | 2.02738182 |
| 124 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.01290508 |
| 125 | Abnormal gallbladder physiology (HP:0012438) | 2.01146986 |
| 126 | Cholecystitis (HP:0001082) | 2.01146986 |
| 127 | Absent epiphyses (HP:0010577) | 2.00860282 |
| 128 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 2.00860282 |
| 129 | Lymphoma (HP:0002665) | 2.00010037 |
| 130 | Absent thumb (HP:0009777) | 1.99670022 |
| 131 | Abnormality of reticulocytes (HP:0004312) | 1.97657970 |
| 132 | Calcaneovalgus deformity (HP:0001848) | 1.96489219 |
| 133 | Respiratory failure (HP:0002878) | 1.95974705 |
| 134 | Ventricular tachycardia (HP:0004756) | 1.95362231 |
| 135 | Postnatal microcephaly (HP:0005484) | 1.94984592 |
| 136 | Personality changes (HP:0000751) | 1.92939227 |
| 137 | Agnosia (HP:0010524) | 1.92766792 |
| 138 | Pulmonary fibrosis (HP:0002206) | 1.92423968 |
| 139 | Achilles tendon contracture (HP:0001771) | 1.92195973 |
| 140 | Myelodysplasia (HP:0002863) | 1.91578086 |
| 141 | Type 2 muscle fiber atrophy (HP:0003554) | 1.91535973 |
| 142 | Abnormality of serum amino acid levels (HP:0003112) | 1.91444267 |
| 143 | Subaortic stenosis (HP:0001682) | 1.90929174 |
| 144 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.90929174 |
| 145 | Meckel diverticulum (HP:0002245) | 1.90528498 |
| 146 | Type I transferrin isoform profile (HP:0003642) | 1.90009852 |
| 147 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.89805544 |
| 148 | Nausea (HP:0002018) | 1.89178575 |
| 149 | Spinal rigidity (HP:0003306) | 1.89060588 |
| 150 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.88829113 |
| 151 | Frequent falls (HP:0002359) | 1.88317157 |
| 152 | Exercise intolerance (HP:0003546) | 1.87324157 |
| 153 | Hyperammonemia (HP:0001987) | 1.87162510 |
| 154 | Malignant hyperthermia (HP:0002047) | 1.86767094 |
| 155 | Hypoplasia of the uterus (HP:0000013) | 1.85430894 |
| 156 | Dicarboxylic aciduria (HP:0003215) | 1.84397105 |
| 157 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.84397105 |
| 158 | Neoplasm of the pancreas (HP:0002894) | 1.84365936 |
| 159 | Difficulty climbing stairs (HP:0003551) | 1.84253400 |
| 160 | Reduced antithrombin III activity (HP:0001976) | 1.84236367 |
| 161 | Rhabdomyosarcoma (HP:0002859) | 1.84108145 |
| 162 | Neoplasm of head and neck (HP:0012288) | 1.83998920 |
| 163 | Esophageal neoplasm (HP:0100751) | 1.83998920 |
| 164 | Microcytic anemia (HP:0001935) | 1.83475862 |
| 165 | Abnormality of the umbilical cord (HP:0010881) | 1.82184391 |
| 166 | Abnormal atrioventricular conduction (HP:0005150) | 1.81429194 |
| 167 | Fetal akinesia sequence (HP:0001989) | 1.80481486 |
| 168 | Abnormal gallbladder morphology (HP:0012437) | 1.77532119 |
| 169 | Foot dorsiflexor weakness (HP:0009027) | 1.76745741 |
| 170 | Abnormality of the Achilles tendon (HP:0005109) | 1.76160668 |
| 171 | Weak cry (HP:0001612) | 1.75676468 |
| 172 | Limb-girdle muscle atrophy (HP:0003797) | 1.74489934 |
| 173 | Axonal loss (HP:0003447) | 1.73302670 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BUB1 | 4.98490569 |
| 2 | OBSCN | 4.92612123 |
| 3 | WEE1 | 4.21295791 |
| 4 | NME2 | 3.67478636 |
| 5 | TTN | 3.54267646 |
| 6 | EIF2AK1 | 3.34519280 |
| 7 | CDC7 | 3.20229785 |
| 8 | PHKG1 | 3.01442683 |
| 9 | PHKG2 | 3.01442683 |
| 10 | LIMK1 | 2.93582612 |
| 11 | STK16 | 2.70062325 |
| 12 | ACVR1B | 2.64760115 |
| 13 | NEK2 | 2.62245712 |
| 14 | PLK4 | 2.54588315 |
| 15 | TESK2 | 2.34737205 |
| 16 | DYRK3 | 2.15060812 |
| 17 | EIF2AK3 | 2.14606703 |
| 18 | ERN1 | 2.11473451 |
| 19 | VRK1 | 2.04820846 |
| 20 | CCNB1 | 1.96240168 |
| 21 | BRSK2 | 1.93619054 |
| 22 | VRK2 | 1.93216554 |
| 23 | TTK | 1.89279480 |
| 24 | NME1 | 1.83060558 |
| 25 | BCKDK | 1.81256205 |
| 26 | TLK1 | 1.79598205 |
| 27 | PDK2 | 1.73339000 |
| 28 | SCYL2 | 1.72397328 |
| 29 | PLK1 | 1.71359507 |
| 30 | IRAK3 | 1.68818933 |
| 31 | SRPK1 | 1.64538412 |
| 32 | NEK1 | 1.58898026 |
| 33 | AURKB | 1.55729893 |
| 34 | TSSK6 | 1.53490369 |
| 35 | BRSK1 | 1.49494453 |
| 36 | MAP4K1 | 1.48282446 |
| 37 | AURKA | 1.42038139 |
| 38 | CDK7 | 1.39542361 |
| 39 | MYLK | 1.36898610 |
| 40 | TBK1 | 1.32104267 |
| 41 | MAP3K8 | 1.29801357 |
| 42 | PASK | 1.29582575 |
| 43 | CDK8 | 1.27455887 |
| 44 | KDR | 1.27022090 |
| 45 | TAOK2 | 1.23928693 |
| 46 | PIM2 | 1.19831365 |
| 47 | STK10 | 1.16735851 |
| 48 | ATR | 1.15418338 |
| 49 | CHEK2 | 1.15094982 |
| 50 | CDK4 | 1.15009401 |
| 51 | CDK19 | 1.10172870 |
| 52 | BRAF | 1.08793322 |
| 53 | RAF1 | 1.05473933 |
| 54 | ARAF | 1.05423606 |
| 55 | MAP3K11 | 1.05406835 |
| 56 | LMTK2 | 1.05243634 |
| 57 | CAMK2G | 1.04807032 |
| 58 | MAPK12 | 1.01459314 |
| 59 | RPS6KB2 | 1.00772251 |
| 60 | PIK3CG | 0.99536255 |
| 61 | TAOK3 | 0.93301638 |
| 62 | TRIB3 | 0.87842606 |
| 63 | ICK | 0.83299812 |
| 64 | LRRK2 | 0.81882788 |
| 65 | MAP2K2 | 0.80913385 |
| 66 | DYRK2 | 0.79705651 |
| 67 | PLK3 | 0.79594399 |
| 68 | RPS6KA4 | 0.78865690 |
| 69 | PRKD3 | 0.74106124 |
| 70 | CHEK1 | 0.73721159 |
| 71 | ZAP70 | 0.73677624 |
| 72 | MAPKAPK3 | 0.69478134 |
| 73 | EPHB2 | 0.69022328 |
| 74 | AKT2 | 0.68866184 |
| 75 | ABL2 | 0.68203366 |
| 76 | PBK | 0.68030682 |
| 77 | TEC | 0.66826655 |
| 78 | PAK1 | 0.64928283 |
| 79 | EEF2K | 0.64356052 |
| 80 | MAP3K12 | 0.64151159 |
| 81 | MAP3K1 | 0.63722240 |
| 82 | GRK6 | 0.63525498 |
| 83 | CSNK2A1 | 0.63327050 |
| 84 | DAPK3 | 0.62868764 |
| 85 | PDPK1 | 0.62837613 |
| 86 | CAMK2D | 0.62385670 |
| 87 | ILK | 0.62104668 |
| 88 | ZAK | 0.61991835 |
| 89 | PRPF4B | 0.61698882 |
| 90 | MKNK2 | 0.59568760 |
| 91 | MKNK1 | 0.58829869 |
| 92 | MAPK4 | 0.57427363 |
| 93 | PIM1 | 0.57065987 |
| 94 | CSNK2A2 | 0.56055421 |
| 95 | MST4 | 0.55271786 |
| 96 | EPHB1 | 0.54495070 |
| 97 | MAP3K3 | 0.54140024 |
| 98 | BTK | 0.53511585 |
| 99 | CSNK1G3 | 0.52687685 |
| 100 | PRKCI | 0.51724544 |
| 101 | KSR2 | 0.50185216 |
| 102 | DAPK1 | 0.49659153 |
| 103 | PRKD1 | 0.49020546 |
| 104 | CDK2 | 0.48626256 |
| 105 | FLT3 | 0.46819410 |
| 106 | SMG1 | 0.45731348 |
| 107 | SIK1 | 0.45559876 |
| 108 | MAP2K3 | 0.45368556 |
| 109 | EPHA2 | 0.44648828 |
| 110 | RIPK1 | 0.42381921 |
| 111 | PKN2 | 0.41882447 |
| 112 | PDK3 | 0.40704323 |
| 113 | PDK4 | 0.40704323 |
| 114 | TGFBR1 | 0.40647813 |
| 115 | MAP3K5 | 0.40597524 |
| 116 | ATM | 0.39702575 |
| 117 | MAP3K10 | 0.39105708 |
| 118 | EIF2AK2 | 0.39075361 |
| 119 | TESK1 | 0.38770558 |
| 120 | MAPKAPK5 | 0.38251755 |
| 121 | CAMK2B | 0.37407540 |
| 122 | MOS | 0.36976486 |
| 123 | SYK | 0.36463485 |
| 124 | CDK14 | 0.36411921 |
| 125 | NLK | 0.35557255 |
| 126 | MUSK | 0.34624531 |
| 127 | PRKG2 | 0.32950442 |
| 128 | MAP3K13 | 0.32824959 |
| 129 | BLK | 0.32604090 |
| 130 | TYK2 | 0.32461844 |
| 131 | IKBKB | 0.31846135 |
| 132 | STK4 | 0.31272785 |
| 133 | MAP2K1 | 0.31084991 |
| 134 | MELK | 0.30759571 |
| 135 | CSNK1G2 | 0.30620731 |
| 136 | MAPK11 | 0.30219401 |
| 137 | KIT | 0.30089280 |
| 138 | CDK1 | 0.29932824 |
| 139 | MAP3K6 | 0.29539058 |
| 140 | PAK4 | 0.29193884 |
| 141 | RPS6KA2 | 0.28991833 |
| 142 | ROCK1 | 0.28403860 |
| 143 | MAP2K7 | 0.28375041 |
| 144 | PINK1 | 0.27788002 |
| 145 | CDK11A | 0.27638725 |
| 146 | MST1R | 0.27169947 |
| 147 | STK38L | 0.26525033 |
| 148 | PKN1 | 0.26283604 |
| 149 | CDK15 | 0.25892315 |
| 150 | RPS6KA5 | 0.25652487 |
| 151 | CSNK1A1L | 0.25592569 |
| 152 | GRK7 | 0.22966554 |
| 153 | PDK1 | 0.22928477 |
| 154 | PRKAA2 | 0.22323282 |
| 155 | CDK18 | 0.21552069 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 5.24970805 |
| 2 | Mismatch repair_Homo sapiens_hsa03430 | 4.08212833 |
| 3 | Ribosome_Homo sapiens_hsa03010 | 4.01908499 |
| 4 | Proteasome_Homo sapiens_hsa03050 | 3.70080446 |
| 5 | RNA polymerase_Homo sapiens_hsa03020 | 3.55042954 |
| 6 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.48494195 |
| 7 | Fatty acid elongation_Homo sapiens_hsa00062 | 3.21175069 |
| 8 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 3.18765845 |
| 9 | Homologous recombination_Homo sapiens_hsa03440 | 3.11376468 |
| 10 | Base excision repair_Homo sapiens_hsa03410 | 3.05336628 |
| 11 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.86579529 |
| 12 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.73743529 |
| 13 | Spliceosome_Homo sapiens_hsa03040 | 2.72981359 |
| 14 | RNA transport_Homo sapiens_hsa03013 | 2.48664818 |
| 15 | Cell cycle_Homo sapiens_hsa04110 | 2.40126142 |
| 16 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.03723469 |
| 17 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.96756345 |
| 18 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.96128418 |
| 19 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.94292757 |
| 20 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.89104353 |
| 21 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.84740778 |
| 22 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.82203375 |
| 23 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.69628837 |
| 24 | Basal transcription factors_Homo sapiens_hsa03022 | 1.64436803 |
| 25 | RNA degradation_Homo sapiens_hsa03018 | 1.62331463 |
| 26 | Purine metabolism_Homo sapiens_hsa00230 | 1.58956383 |
| 27 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.58891983 |
| 28 | Parkinsons disease_Homo sapiens_hsa05012 | 1.56931045 |
| 29 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.56280236 |
| 30 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.55751107 |
| 31 | Sulfur relay system_Homo sapiens_hsa04122 | 1.51941987 |
| 32 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.51797312 |
| 33 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.45663021 |
| 34 | Protein export_Homo sapiens_hsa03060 | 1.40581380 |
| 35 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.37139440 |
| 36 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.34666555 |
| 37 | Huntingtons disease_Homo sapiens_hsa05016 | 1.29220100 |
| 38 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.28801909 |
| 39 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.28343149 |
| 40 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.27521841 |
| 41 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.26071701 |
| 42 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.21163802 |
| 43 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.19885702 |
| 44 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.14381009 |
| 45 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.13242238 |
| 46 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.07929262 |
| 47 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.07735547 |
| 48 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.06274614 |
| 49 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.99339507 |
| 50 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.96245121 |
| 51 | Carbon metabolism_Homo sapiens_hsa01200 | 0.95494914 |
| 52 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.91279045 |
| 53 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.90394353 |
| 54 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.86437953 |
| 55 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.85740075 |
| 56 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.85228785 |
| 57 | Lysosome_Homo sapiens_hsa04142 | 0.84123792 |
| 58 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.82083121 |
| 59 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.81917075 |
| 60 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.81207336 |
| 61 | Alzheimers disease_Homo sapiens_hsa05010 | 0.80488434 |
| 62 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.75979744 |
| 63 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.75551661 |
| 64 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.70308642 |
| 65 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.65327951 |
| 66 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.64511330 |
| 67 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.64102953 |
| 68 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.62865641 |
| 69 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.61760128 |
| 70 | Metabolic pathways_Homo sapiens_hsa01100 | 0.61462856 |
| 71 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.61210419 |
| 72 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.60225145 |
| 73 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.59587860 |
| 74 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.58690112 |
| 75 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.58660329 |
| 76 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.57587567 |
| 77 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.57303244 |
| 78 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.56735004 |
| 79 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.56119704 |
| 80 | Prion diseases_Homo sapiens_hsa05020 | 0.54553673 |
| 81 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.52464653 |
| 82 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.49006085 |
| 83 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.48855391 |
| 84 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.48636484 |
| 85 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.48584257 |
| 86 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.48384439 |
| 87 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.47850186 |
| 88 | Thyroid cancer_Homo sapiens_hsa05216 | 0.47210519 |
| 89 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.44773978 |
| 90 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.43548753 |
| 91 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.42251963 |
| 92 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.41859620 |
| 93 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.40314249 |
| 94 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.40207921 |
| 95 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.40024802 |
| 96 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.38808988 |
| 97 | Galactose metabolism_Homo sapiens_hsa00052 | 0.37492733 |
| 98 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.37045670 |
| 99 | HTLV-I infection_Homo sapiens_hsa05166 | 0.36004769 |
| 100 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.35805423 |
| 101 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.31420142 |
| 102 | Salmonella infection_Homo sapiens_hsa05132 | 0.29117643 |
| 103 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.29016174 |
| 104 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.28523935 |
| 105 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.27920919 |
| 106 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.26012466 |
| 107 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.24916455 |
| 108 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.24512281 |
| 109 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.24457869 |
| 110 | Peroxisome_Homo sapiens_hsa04146 | 0.23677874 |
| 111 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.22180144 |
| 112 | Insulin resistance_Homo sapiens_hsa04931 | 0.21800324 |
| 113 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.21448355 |
| 114 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.20205048 |
| 115 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.20176709 |
| 116 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.19426410 |
| 117 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.19420477 |
| 118 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.18815813 |
| 119 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.17875186 |
| 120 | Other glycan degradation_Homo sapiens_hsa00511 | 0.17648202 |
| 121 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.17468802 |
| 122 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.17462165 |
| 123 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.15942860 |
| 124 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.13836064 |
| 125 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.13472803 |
| 126 | Shigellosis_Homo sapiens_hsa05131 | 0.13447658 |
| 127 | Apoptosis_Homo sapiens_hsa04210 | 0.11735267 |
| 128 | Bladder cancer_Homo sapiens_hsa05219 | 0.10942022 |
| 129 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.10116452 |
| 130 | Legionellosis_Homo sapiens_hsa05134 | 0.09816295 |
| 131 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.08933558 |
| 132 | Alcoholism_Homo sapiens_hsa05034 | 0.08687083 |
| 133 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.08681956 |
| 134 | Hepatitis B_Homo sapiens_hsa05161 | 0.06951423 |
| 135 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.06218662 |
| 136 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.05849480 |
| 137 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.02535546 |
| 138 | Glycerolipid metabolism_Homo sapiens_hsa00561 | -0.0535516 |
| 139 | Acute myeloid leukemia_Homo sapiens_hsa05221 | -0.0454928 |
| 140 | Small cell lung cancer_Homo sapiens_hsa05222 | -0.0431590 |
| 141 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | -0.0385293 |
| 142 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | -0.0283820 |
| 143 | Measles_Homo sapiens_hsa05162 | -0.0256416 |

